Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.8%

1 terminated/withdrawn out of 21 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

24%

5 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(33.3%)
Phase 3
3(25.0%)
Phase 1
2(16.7%)
Phase 4
2(16.7%)
Phase 2
1(8.3%)
12Total
N/A(4)
Phase 3(3)
Phase 1(2)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT07303985Phase 3Completed

The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction

Role: lead

NCT07461285Not ApplicableNot Yet Recruiting

Perioperative Prophylactic Positive Pressure Ventilation Reduces Postoperative Pulmonary Complications.

Role: lead

NCT07000760Phase 3Completed

Intraoperative Nebulization of Lidocaine and Postoperative Pulmonary Complications

Role: lead

NCT07331441Not ApplicableNot Yet Recruiting

External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery

Role: lead

NCT06120439Not ApplicableCompleted

Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

Role: lead

NCT06565715Phase 4Completed

Effect of Remazolam on Hemodynamics During Hepatectomy

Role: lead

NCT06561633Completed

The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex

Role: lead

NCT02710851Phase 2Unknown

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Role: lead

NCT04969445Unknown

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Role: lead

NCT05045755Unknown

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Role: lead

NCT04704908Unknown

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Role: lead

NCT04360629Not ApplicableCompleted

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Role: lead

NCT02405520Phase 1Completed

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Role: lead

NCT02188004Completed

The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases

Role: lead

NCT02645396Completed

A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China

Role: lead

NCT03206255Completed

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Role: lead

NCT02189603Phase 4Completed

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

Role: lead

NCT02562508Phase 3Completed

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Role: lead

NCT02710864Completed

A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China

Role: lead

NCT02018523Phase 1Terminated

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Role: lead